|
Jan 3
|
Evotec Announces CEO Transition
|
|
Dec 19
|
Evotec receives US$ 2.5 M Grant to Leverage Human iPSC-Derived Teratogenicity Platform for Global Health Programmes
|
|
Dec 14
|
Evotec Enters Partnership with Charité to Expand Molecular Patient Database in Autoimmune Diseases
|
|
Dec 6
|
Evotec-partner Jingxin Receives Approval for EVT201 in China
|
|
Dec 4
|
Evotec SE's (ETR:EVT) largest shareholders are individual investors with 47% ownership, institutions own 34%
|
|
Dec 1
|
‘From Hype to Clinical‘: Cowen Suggests 2 AI Healthcare Stocks to Consider
|
|
Nov 15
|
Evotec Presents Precision Medicine Platforms for Accelerated Pipeline Building at Capital Markets Day
|
|
Jun 29
|
Evotec Receives Milestone Payment for First Patient Dosed in Phase I Study of Bayer Kidney Disease Programme
|